The increasing incidence of diabetes has mandated effective diabetes management. The classification of sensor detected glucose levels into various ranges has successfully enabled this. Additionally, continuous glucose monitoring and greater time-in-range (TIR) results in fewer microvascular endpoints. TIR monitoring also enables a personalized approach and better management of diabetes. Moreover, it is an excellent predictor of diabetes-related complications. In this regard, Docplexus has organized an exclusive webinar on 26 th July 2021, from 3 PM onwards.
In this webinar, Dr. A. G. Unnikrishnan , a leading expert in endocrinology, will be sharing his insights on “Clinical Perspectives of Time-in-range and Diabetes Management”. Key points of discussion: The need for a new measure of glycemia Basic aspects of TIR and comparison to HbA1c Application of TIR as a clinical tool, with case…
